Stock listing

NASDAQ:LOGC LogicBio Therapeutics Inc Stock

Follow LogicBio Therapeutics Inc into a list and get an email when it puts out news.

Delisted NASDAQ:LOGC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:LOGC
Asset type
Stock
Exchange
NASDAQ
Currency
USD

LogicBio Therapeutics Inc on 6ix

Decks
1 deck · latest Jan 12, 2021

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 10, 2026+0.3%
Quarter to Jun 30, 2026Aug 14, 2026+6.6%
Quarter to Mar 31, 2026May 15, 2026+1.1%
Quarter to Dec 31, 2025Mar 6, 2026+1.5%
Quarter to Sep 30, 2025Oct 28, 2025+1.6%
Quarter to Jun 30, 2025Aug 7, 2025 · After close−1.2%
Quarter to Mar 31, 2025May 9, 2025 · After close+2.6%
Quarter to Dec 31, 2024Mar 3, 2025 · Before open−7.8%
Quarter to Sep 30, 2024Nov 7, 2024 · After close+1.4%
Quarter to Jun 30, 2024Aug 8, 2024 · After close−0.6%
All 20 quarters
QuarterResultsShare move
Quarter to Mar 31, 2024May 8, 2024 · After close−2.3%
Quarter to Dec 31, 2023Mar 4, 2024 · After close−1.7%
Quarter to Sep 30, 2023Nov 7, 2023 · After close+25.1%
Quarter to Jun 30, 2023Aug 3, 2023 · After close−25.5%
Quarter to Mar 31, 2023May 4, 2023 · After close−2.1%
Quarter to Dec 31, 2022Feb 23, 2023 · After close−28.7%
Quarter to Sep 30, 2022Nov 9, 2022 · After close+15.3%
Quarter to Jun 30, 2022Aug 9, 2022 · After close+1.2%
Quarter to Mar 31, 2022May 5, 2022 · After close−5.3%
Quarter to Dec 31, 2021Mar 1, 2022 · After close−5.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2021)Investor deck43 slidesJan 12, 2021

Open Decks

Cap table

Built by 6ix from LogicBio Therapeutics Inc’s releases · as of Jul 31, 2026

Common shares
45,753,716
Fully diluted
45,753,716

Fully diluted

LineSharesAs of
Common shares45,753,716Jul 31, 2026

Share count over time

CountShares
Jul 31, 202645,753,716

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark Enyedy
Other companies: Charles River Laboratories International, Inc. (Director · Since at least May 20, 2025); BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 5, 2020 · Past); Keryx Biopharmaceuticals Inc (Director · Jun 30, 2018 – Dec 12, 2018 · Past); ImmunoGen Inc (CHIEF EXECUTIVE OFFICER, Director · Feb 15, 2018 – Feb 12, 2024 · Past)
Director · Mar 17, 2020 – Nov 16, 2022 · Past
Daphne Karydas
Other companies: COMPASS Pathways Plc (INDEPENDENT DIRECTOR · Since at least Sep 18, 2023); Mineralys Therapeutics, Inc. (Board Member · Since at least Sep 13, 2023); Syndax Pharmaceuticals, Inc. (Chief Financial Officer · Feb 3, 2021 – Feb 3, 2021 · Past); Eucrates Biomedical Acquisition Corp. (Director · Oct 23, 2020 – Oct 23, 2020 · Past)
Director · Dec 10, 2020 – Nov 16, 2022 · Past
Tomer Kariv
Other companies: Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); 89bio Inc (Director · Nov 8, 2019 – Nov 11, 2019 · Past); VBI Vaccines Inc. (Director · Jan 23, 2018 – Jan 31, 2019 · Past); Arno Therapeutics Inc (Director · Jan 12, 2016 – Sep 8, 2016 · Past)
Director · Oct 18, 2018 – Dec 19, 2019 · Past
Jeff Goater
Other companies: Vaccinex, Inc. (Director · Aug 9, 2018 – May 11, 2021 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Sep 8, 2023 · Past)
Director · Dec 10, 2020 – Nov 16, 2022 · Past
Leon Chen
Other companies: Eikon Therapeutics, Inc. (Director · Since at least Feb 4, 2026); Nurix Therapeutics, Inc. (Director · Jul 23, 2020 – May 6, 2021 · Past)
Director · Oct 18, 2018 – Nov 16, 2022 · Past
Seokho Bryan Yoon
Other companies: Terns Pharmaceuticals, Inc. (COO and General Counsel · Feb 4, 2021 – May 31, 2024 · Past); Nightstar Therapeutics PLC (General Counsel and Secretary · Jan 1, 2019 – Jun 6, 2019 · Past)
Chief Admin Officer & GC · Nov 11, 2019 – Apr 15, 2020 · Past
Cecilia Jones
Other companies: Agios Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Sep 26, 2022)
Chief Financial Officer · Jan 11, 2021 – Mar 1, 2022 · Past
Richard A Moscicki
Other companies: Akcea Therapeutics Inc (Director · Jun 1, 2018 – Jun 14, 2019 · Past)
Director · Oct 18, 2018 – Nov 16, 2022 · Past
Daniel GruskinChief Medical Officer · May 19, 2021 – Nov 16, 2022 · Past
Matthias JaffeChief Financial Officer · Oct 18, 2018 – Apr 15, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about LogicBio Therapeutics Inc.